So in typical medical badminton fashion, a study was published in JAMA today stating the opposite , that ADT was not associated with an increase risk of cardiovascular events. Well, who's right? These authors claimed the upper hand because their conclusion was based upon a meta-analysis of 8 randomized controlled trials (RCT) involving 4,141 patients followed for 7-13yrs, rather than a rehash of epidemiological studies. But what are we to do in the meantime while we wait for a more definitive answer? Let's realize that many of the same patients w/prostate cancer are also dealing w/heart disease. Regardless of how ADT affects their cardiovascular event rate, these patients must have their heart disease risk factors aggressively treated. And for now, the major medical groups haven't rescinded their collective guideline.Follow @alvinblin
|
Write a comment:
|